126 related articles for article (PubMed ID: 10410636)
41. Communication development of a young child with foetal retinoid syndrome: a seven-year follow-up study.
Kritzinger A; Steenkamp L
S Afr J Commun Disord; 2006; 53():39-48. PubMed ID: 20218489
[TBL] [Abstract][Full Text] [Related]
42. Changes in isotretinoin prescribing before and after implementation of the System to Manage Accutane Related Teratogenicity (SMART) risk management program.
Mendelsohn AB; Governale L; Trontell A; Seligman P
Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):615-8. PubMed ID: 15892175
[TBL] [Abstract][Full Text] [Related]
43. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris.
Zane LT; Leyden WA; Marqueling AL; Manos MM
Arch Dermatol; 2006 Aug; 142(8):1016-22. PubMed ID: 16924051
[TBL] [Abstract][Full Text] [Related]
44. Pregnancy prevention among women taking isotretinoin: failure to comply with the recommendations.
Boucher N; Beaulac-Baillargeon L
Can Fam Physician; 2006 Mar; 52(3):338-9. PubMed ID: 16926960
[TBL] [Abstract][Full Text] [Related]
45. Oral isotretinoin and haemophilia A.
Bettoli V; Pizzigoni S; Vasina S; Mancino A; Virgili A
J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):718-20. PubMed ID: 15482307
[TBL] [Abstract][Full Text] [Related]
46. The need for restricted prescription of retinoic acid derivative isotretinoin to prevent retinoid teratogenicity.
De Santis M; Straface G; Cavaliere A; Nobili E; Caruso A
Prev Med; 2007; 45(2-3):243-4. PubMed ID: 17640721
[No Abstract] [Full Text] [Related]
47. The cost of clear skin: balancing the social and safety costs of iPLEDGE with the efficacy of Accutane (isotretinoin).
Doshi A
Seton Hall Law Rev; 2007; 37(2):625-60. PubMed ID: 17294569
[No Abstract] [Full Text] [Related]
48. Maternal and fetal toxicity of N-methylmorpholine by oral administration in rats.
Sitarek K
Teratog Carcinog Mutagen; 1999; 19(6):369-76. PubMed ID: 10587407
[TBL] [Abstract][Full Text] [Related]
49. A risk management program aimed at preventing fetal exposure to isotretinoin: retrospective cohort study.
Cheetham TC; Wagner RA; Chiu G; Day JM; Yoshinaga MA; Wong L
J Am Acad Dermatol; 2006 Sep; 55(3):442-8. PubMed ID: 16908350
[TBL] [Abstract][Full Text] [Related]
50. [Treatment of acne by isotretinoin (general course)].
Chivot M
Rev Prat; 2002 Apr; 52(8):845-9. PubMed ID: 12053792
[TBL] [Abstract][Full Text] [Related]
51. Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin.
Karalezli A; Borazan M; Altinors DD; Dursun R; Kiyici H; Akova YA
Cornea; 2009 Jan; 28(1):46-50. PubMed ID: 19092405
[TBL] [Abstract][Full Text] [Related]
52. The use and abuse of drugs in pregnancy.
Cameron IT
Br J Hosp Med; 1984 Oct; 32(4):182, 184, 186. PubMed ID: 6487878
[No Abstract] [Full Text] [Related]
53. Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients' outcome assessment.
Soria A; Canoui-Poitrine F; Wolkenstein P; Poli F; Gabison G; Pouget F; Viallette C; Revuz J
Dermatology; 2009; 218(2):134-5. PubMed ID: 19060466
[TBL] [Abstract][Full Text] [Related]
54. A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin.
Ferahbas A; Turan MT; Esel E; Utas S; Kutlugun C; Kilic CG
J Dermatolog Treat; 2004 Jun; 15(3):153-7. PubMed ID: 15204147
[TBL] [Abstract][Full Text] [Related]
55. A practical approach for the use of oral isotretinoin for infantile acne.
Barnes CJ; Eichenfield LF; Lee J; Cunningham BB
Pediatr Dermatol; 2005; 22(2):166-9. PubMed ID: 15804310
[TBL] [Abstract][Full Text] [Related]
56. iPLEDGE allegiance to the pill: evaluation of year 1 of a birth defect prevention and monitoring system.
Schonfeld TL; Amoura NJ; Kratochvil CJ
J Law Med Ethics; 2009; 37(1):104-17. PubMed ID: 19245607
[TBL] [Abstract][Full Text] [Related]
57. Effects of oral isotretinoin therapy on peripheral nerve functions.
Chroni E; Pasmatzi E; Monastirli A; Georgiou S; Polychronopoulos P; Tsambaos D
Clin Exp Dermatol; 2008 Mar; 33(2):191-2. PubMed ID: 18076687
[No Abstract] [Full Text] [Related]
58. Isotretinoin--a newly recognized human teratogen.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1984 Apr; 33(13):171-3. PubMed ID: 6422237
[No Abstract] [Full Text] [Related]
59. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations.
Dréno B; Bettoli V; Ochsendorf F; Perez-Lopez M; Mobacken H; Degreef H; Layton A
Eur J Dermatol; 2006; 16(5):565-71. PubMed ID: 17101480
[TBL] [Abstract][Full Text] [Related]
60. Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid.
Nau H
J Am Acad Dermatol; 2001 Nov; 45(5):S183-7. PubMed ID: 11606951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
